Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • Dr. Jennifer Hoy: How to Safely Transition ART in HIV Patients Achieving Viral Suppression?

    Infectious Disease/HIV Specialist and Medical Professor at Monash University Alfred Hospital, Australia. Member of the Australian Antiretroviral Guidelines Committee and the International Antiviral Society-USA (IAS-USA) Antiretroviral Guidelines Panel. Leading and participating in the development of new antiretroviral drugs and the prevention and management of opportunistic infections, with a primary research focus on complications related to aging in…

    2024.02.19
  • What new concepts and methods have gut microbiome research brought to the diagnosis and treatment of autoimmune liver disease?

    2024.02.19
  • 《Hematology frontier》Wishing all medical colleagues a happy Lunar New Year

    2024.02.18
  • How to improve HCV screening?

    2024.02.18
  • The main highlights of 2023 AASLD Annual Meeting

    2024.02.18
  • How can patients perceive and actively manage MASLD on their own?

    2024.02.18
  • Current treatment status and challenges for intermediate and advanced stage HCC

    2024.02.18
  • The mechanism of tumor microenvironment affecting the occurrence and development of HCC

    2024.02.18
«previous next»
Recent Posts
  • 2026 Pujiang Urological Oncology Academic Conference丨Chunguang Ma: Immunotherapy Opens a New Era in Adjuvant Treatment for Urothelial Carcinoma—From a Shift in Perioperative Concepts to Precision Whole-Course Management
  • Professor Yongmei Yin: Advancing Precision Oncology from Concept to Clinical Practice — Key Insights from the 2026 “Renyi” Clinical Research Conference on Innovative Anticancer Drugs
  • 2026 Northern Breast Cancer Salon · Getting to the Bottom of It丨Professors Wenyan Chen and Ning Xie: Treatment Options for HER2-Positive Metastatic Breast Cancer After Failure of H-Based Therapy
  • 2026 Northern Breast Cancer Salon · Time & Memory丨Professor Guohong Song: Breaking New Ground and Advancing Further — The Evolution of HER2-Positive Breast Cancer Treatment and the New Treatment Landscape in the ADC Era
  • 2026 Northern Breast Cancer Salon · Time & Memory | Professor Yongmei Yin: Seeing the Subtle to Foresee the Far — The Evolution of Precision Diagnosis and Treatment in Breast Cancer from Molecular Subtyping to Gene-Guided Therapy
Recent Comments
    Archives
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top